Sign In
Buy CHE
$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail
04:46pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.
Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail
02:17pm, Friday, 02'nd Sep 2022
Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.
Here's Why You Should Hold on to Chemed (CHE) Stock Now
04:52pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and impressive Roto-Rooter results.
PNTG vs. CHE: Which Stock Should Value Investors Buy Now?
03:40pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
PNTG vs. CHE: Which Stock Is the Better Value Option?
Dividend Champion, Contender, And Challenger Highlights: Week Of August 28
04:23am, Sunday, 28'th Aug 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here for an update on dividend stocks for the week of Aug 28.
Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns
01:13pm, Friday, 26'th Aug 2022
Chemed continues to demonstrate the factors of resiliency that investors are paying a premium for in H2 FY22. The company presents with above-market return on invested capital whilst NOPAT and FCF rem
The Zacks Analyst Blog Highlights H&R Block, Chemed, Suncor Energy, Open Text and Essent Group
10:07am, Friday, 12'th Aug 2022 Zacks Investment Research
H&R Block, Chemed, Suncor Energy, Open Text and Essent Group are part of the Zacks top Analyst Blog.
Chemtrade Logistics Income Fund (CGIFF) CEO Scott Rook on Q2 2022 Results - Earnings Call Transcript
07:32pm, Thursday, 11'th Aug 2022
Chemtrade Logistics Income Fund (OTC:CGIFF) Q2 2023 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and Chief
5 Stocks in Focus That Recently Hiked Their Dividends
12:04pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Investors should consider stocks that have recently raised their dividend payments. These are: HRB, CHE, SU, OTEX, ESNT.
5 Stocks in Focus That Recently Hiked Their Dividends
09:47am, Thursday, 11'th Aug 2022
Investors should consider stocks that have recently raised their dividend payments. These are: HRB, CHE, SU, OTEX, ESNT.
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
05:57pm, Friday, 29'th Jul 2022 Zacks Investment Research
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
03:33pm, Friday, 29'th Jul 2022
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2022 Results - Earnings Call Transcript
02:03pm, Thursday, 28'th Jul 2022
Chemed Corporation (NYSE:CHE ) Q2 2022 Earnings Conference Call July 28, 2022 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Offi
Chemed (CHE) Q2 Earnings Surpass Estimates
09:55pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Chemed (CHE) delivered earnings and revenue surprises of 1.26% and 1.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Oak Street Health, Inc. (OSH) Surges 5.2%: Is This an Indication of Further Gains?
12:38pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Oak Street Health, Inc. (OSH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the
